1. Immunity-inducing agent containing as effective ingredient (s) at least one polypeptide having immunity-inducing activity, selected from the following polypeptides (a) - (c), and / or recombinant (s) vector (s), which (s) contains (at) polynucleotide (s) encoding (s) the specified at least one polypeptide, where the specified (s) recombinant (s) vector (s) is capable of expressing the specified (s) ) in vivo polypeptide (s): (a) a polypeptide consisting of at least 7 consecutive amino acids in any amino acid a different sequence of SEQ ID NOs: 4, 2, 22, and 24 from the LIST OF SEQUENCES； (b) a polypeptide having a sequence identity of at least 85% relative to said polypeptide and consisting of at least 7 amino acids； and (c) a polypeptide containing said polypeptide (a) or (b) as part of its sequence. The immunity inducing agent according to claim 1, wherein said polypeptide having immunity inducing activity is a polypeptide having the amino acid sequence of SEQ ID NO: 4, 2, 22, or 24 from the SEQUENCE LIST. 3. An immunity inducing agent according to claim 1 or 2, which is an agent for treating antigen presenting cells. The immunity inducing agent according to claim 1 or 2, which is a therapeutic and / or prophylactic agent for use in malignant neoplasm (s). The immunity inducing agent according to claim 4, wherein said malignant neoplasm (s) is (are) malignant neoplasm (s) expressing SCD1.6. The immunity inducing agent according to claim 5, where the specified cancer1. Иммунитет-индуцирующий агент, содержащий в качестве эффективного(ых) ингредиента(ов) по меньшей мере один полипептид, обладающий иммунитет-индуцирующей активностью, выбранный из нижеуказанных полипептидов (а)-(с), и/или рекомбинантный(ые) вектор(ы), который(ые) содержит(ат) полинуклеотид(ы), кодирующий(ие) указанный по меньшей мере один полипептид, где указанный(ые) рекомбинантный(ые) вектор(ы), способен(ны) экспрессировать указанный(ые) полипептид(ы) in vivo:(а) полипептид, состоящий из не менее
